Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Identifying Trading Partners Under the Drug Supply Chain Security Act Guidance for Industry

Identifying Trading Partners Under the Drug Supply Chain Security Act Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

August 18, 2017

December 1, 2018

Center for Drug Evaluation and Research

c512f2f3-6e75-4820-87ed-3a9903da5fc3

Related Documents

Drug Master Files Guidance for Industry

Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
View Details →

Standardization of Data and Documentation Practices for Product Tracing Guidance for Industry

Guidance DocumentMarch 2, 2018Center for Drug Evaluation and Research
View Details →

Identifying Trading Partners Under the Drug Supply Chain Security Act

Guidance DocumentJuly 5, 2022Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.